Company Details
  • Conbott Pharmtech Co.,Ltd.

  •  [Zhejiang,China]
  • Business Type:Manufacturer
  • Main Markets: Africa , Americas , Asia , Caribbean , East Europe , Europe , Middle East , North Europe , Oceania , Other Markets , West Europe , Worldwide
  • Exporter:71% - 80%
  • Certs:COS, ISO9001, ISO14010, FDA
  • Description:Androgen Receptor Modulator,Selective Androgen Receptor Modulators,Androgen Receptor
Conbott Pharmtech Co.,Ltd. Androgen Receptor Modulator,Selective Androgen Receptor Modulators,Androgen Receptor
Home > Products > Inhibitors > Androgen Receptor Modulator
  • Title
  • All
Online Service
http://www.conbottpharm.comScan to visit

Androgen Receptor Modulator

Product categories of Androgen Receptor Modulator, we are specialized manufacturers from China, Androgen Receptor Modulator, Selective Androgen Receptor Modulators suppliers/factory, wholesale high-quality products of Androgen Receptor R & D and manufacturing, we have the perfect after-sales service and technical support. Look forward to your cooperation!
View: List Grid
Andarine is also called MK-2866, Ostarine CAS 401900-40-1
Andarine is also called MK-2866, Ostarine CAS 401900-40-1

Model No. : 401900-40-1

We are offering in a wide range of Andarine CAS NO 401900 40 1 which is a potent and tissue selective androgen receptor modulator SARM Andarine CAS 401900 40 1 can be processed into a variety of drugs and have different effects It also can treat...

China Manufacturer of Androgen Receptor Modulator
Andarine(MK-2866) CAS 401900-40-1
Andarine(MK-2866) CAS 401900-40-1

Model No. : 401900-40-1

Andarine CAS 401900 40 1 is also called MK 2866 Ostarine GTx 007 and S4 Andarine CAS NO 401900 40 1 is a potent and tissue selective androgen receptor modulator SARM We purchase premium quality raw material to process Ostarine and adopt cutting edge...

High Quality Selective Androgen Receptor Modulators China Supplier

China Androgen Receptor Modulator Suppliers

Prostate cancer is one of the most common cancer in the world, nearly 100 million people increased every year. Because androgens (male hormones) can stimulate the growth of tumor cells, the disease treatment is mainly through block androgen effects, it has limit efficacy and serious side effects. Recent research team discovered a novel class of Androgen Receptor modulators are expected to provide a new treatment of prostate cancer. In the androgen receptor binding test by screening 15,000 synthetic compounds and natural compounds ,the researchers will focus on 3- aniline 1-propanone derivative of a new class of non-steroidal. These compounds may be high affinity in binding with the androgen receptor, thereby blocking the action of receptor-dihydro-androsterone. Androgen binding with its receptor will activate the target genes and promote cell proliferation. The researchers tested these compounds weather affect those cells. Interestingly, some part of the derivative receptor is agonists which has similar biological effects of androgens; while another part of the receptor is modulators which interfere with male hormones. One of the compound is attracted by researchers, which has high activity with androgen receptor after combination and has 82% inhibition of DHEA-induced gene. In addition, it has significantly physiological effects of androgen-induced in cell proliferation and underage male rats . Because of its low cross progesterone receptor, estrogen receptor and glucocorticoid receptor and other related receptors reaction, the develop of this type of androgen receptor antagonist will become a more specific and effective treatment of prostate cancer drug.
Conbottpharm could give you:
1. Best quality in your requirement
2. Competitive price in China market
3. Mature Technical support
4. Professional logistic support
All we want is win-win business. Send yr. inquiries, you will get it!
Copyright © 2021 Conbott Pharmtech Co.,Ltd. All rights reserved.
Communicate with Supplier?Supplier
Tommy Mr. Tommy
What can I do for you?